Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Avanir Pharmaceuticals
Current Parent Company: Otsuka Pharmaceutical
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $115,874,895
Year: 2019
Date: September 26, 2019
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Secondary Offense: kickbacks and bribery
Mega-Scandal: Healthcare Kickbacks
Violation Description: Avanir Pharmaceuticals agreed to pay $103 million to resolve civil False Claims Act allegations ($95.972 million to the federal government and $7 million to the states) and $12.8 million to resolve criminal kickback allegations in a case involving payments to physicians to induce prescriptions of its drug Nuedexta.
Level of Government: federal
Action Type: agency action
Agency: Justice Department Civil Division
Civil or Criminal Case: civil and criminal
Prosecution Agreement: deferred prosecution agreement
HQ Country of Current Parent: Japan
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.